Dongxia Gao
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancer.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.
Journal: Cell reports
Published: February 19, 2026
Utility of RB1 immunohistochemistry for prognostic subtyping of pulmonary large cell neuroendocrine carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: December 15, 2025
TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinoma.
Journal: Histopathology
Published: December 11, 2025
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline Benefit.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: August 13, 2024
Immune Biomarkers on Tissue Microarray Cores Support the Presence of Adjacent Tertiary Lymphoid Structures in Soft Tissue Sarcoma.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 14, 2024
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.
Journal: Journal of cell science
Published: September 23, 2022
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2022
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial.
Journal: Cancers
Published: July 06, 2022
Last Updated: 09/26/2026